CLINICAL_TRIALS
trial_result
· 2022-05-27
Clinical Trial Update: A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation [Phase 2]
Summary
Phase 2 study assessing efficacy and safety of HSK3486 for sedation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Sedation | Phase 2 | Status: COMPLETED